Pharma Journalist 9038 posts 0 comments

Novartis proudly announces that Kisqali (ribociclib) has achieved a score of five out of five on the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale…
Read More...

SMi Reports: new speaker session with Theresa Jeary, Technical Specialist & Scheme Manager, BSI at the Pre-filled Syringes East Coast 2020 conference I am pleased to inform you…
Read More...

Singapore, 21 September 2020 – Messe Düsseldorf Asia announced today that the 13th edition of MEDICAL FAIR ASIA will take place as a digital edition from 9-18 December. MEDICAL FAIR…
Read More...

T-knife GmbH, a next-generation adoptive T-cell company using its proprietary humanized T-cell receptor (HuTCR) mouse platform to treat solid tumors, and Catalent, the leading global…
Read More...

Sanofi and GSK finalized and signed an Advanced purchase agreement with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is…
Read More...

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq (atezolizumab) in combination…
Read More...

Novartis announced results of the final overall survival (OS) analysis from the SOLAR-1 trial, which evaluated Piqray (alpelisib) in combination with fulvestrant, compared to…
Read More...

PURIFY, the annual conference dedicated to Chromatography Purification is getting ready to showcase its next edition – PURIFY’20. PURIFY’19 exceeded the industry expectations…
Read More...

Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein intended to treat solid tumors. Under this agreement, Samsung…
Read More...

Moderna, Inc. and Vertex Pharmaceuticals Incorporated announced a new strategic research collaboration and licensing agreement aimed at the discovery and development of lipid…
Read More...